SYMFI Trademark

Trademark Overview

On Wednesday, April 26, 2017, a trademark application was filed for SYMFI with the United States Patent and Trademark Office. The USPTO has given the SYMFI trademark a serial number of 87426541. The federal status of this trademark filing is REGISTERED as of Tuesday, October 30, 2018. This trademark is owned by Mylan Pharmaceuticals, Inc.. The SYMFI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals preparations for the treatment of HIV-1
symfi

General Information

Serial Number87426541
Word MarkSYMFI
Filing DateWednesday, April 26, 2017
Status700 - REGISTERED
Status DateTuesday, October 30, 2018
Registration Number5596601
Registration DateTuesday, October 30, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements

Goods and ServicesPharmaceuticals preparations for the treatment of HIV-1

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 5, 2017
Primary Code005
First Use Anywhere DateWednesday, April 25, 2018
First Use In Commerce DateWednesday, April 25, 2018

Trademark Owner History

Party NameMylan Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505

Trademark Events

Event DateEvent Description
Monday, October 30, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, October 30, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 30, 2018REGISTERED-PRINCIPAL REGISTER
Friday, September 28, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 27, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 25, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 4, 2018USE AMENDMENT FILED
Tuesday, September 25, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 4, 2018TEAS STATEMENT OF USE RECEIVED
Saturday, May 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 3, 2018SOU EXTENSION 1 GRANTED
Thursday, May 3, 2018SOU EXTENSION 1 FILED
Thursday, May 3, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 24, 2017ASSIGNED TO EXAMINER
Monday, June 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 29, 2017NEW APPLICATION ENTERED

Related Keywords

symfi treatment preparations pharmaceuticals